Zachariah Justin P, Johnson Philip K, Colan Steven D
Section of Pediatric Cardiology, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, 6621 Fannin St WT 19th Floor, Houston, TX, 77030, USA.
Department of Cardiology, Boston Children's Hospital, Boston, MA, USA.
Pediatr Cardiol. 2016 Jun;37(5):932-7. doi: 10.1007/s00246-016-1373-z. Epub 2016 Apr 4.
Clinical events in hypertrophic cardiomyopathy (HCM) patients are related to the degree of hypertrophy. Aortic stiffness in adult HCM patients has been reported to be higher than control patients. Increased stiffness may cause more LV hypertrophy and thus lead to more clinical events. We sought to (a) noninvasively compare aortic structure and function between youth with sarcomeric HCM genotype versus control youth and (b) explore the relation between aortic function and degree of left ventricular (LV) hypertrophy. In a prospective study from a single referral center, clinical, anthropometric, and hemodynamic data were acquired on 28 consecutive pathogenic HCM gene mutation carriers and 26 unrelated controls (mean age 16.3, 50 % girls). Hemodynamic data included applanation tonometry measured central pulse pressure, carotid-femoral pulse wave velocity (CFPWV), reflected wave augmentation index (AIx). In the HCM gene carriers, LV mass-to-volume ratio was extracted from clinically indicated echocardiograms as an index of hypertrophy. Associations were assessed using multivariable adjusted linear regression. The HCM group was comprised of 14 myosin binding protein C3 carriers, 13 myosin heavy chain 7 carriers, and 1 child with both. HCM and control groups did not differ by age, sex, height, body mass index, heart rate, or blood pressure. HCM carriers had significantly lower CFPWV than controls (4.46 ± 0.88 vs. 4.97 ± 0.44 m/s, p = 0.01) and higher AIx magnitude (27 ± 19 vs. 18 ± 7 %, p = 0.04). These associations persisted after adjustment for age, sex, height, heart rate, mean pressure, and medication use. Within the HCM group, LV hypertrophy was related to AIx but not CFPWV. CFPWV nor AIx differed by genotype. Aortic stiffness appears lower, but wave reflection appears higher in youth carrying HCM gene mutations. The degree of wave reflection appears correlated with LV hypertrophy in this high-risk cohort, suggesting that mitigation of wave reflection may possibly attenuate LV hypertrophy.
肥厚型心肌病(HCM)患者的临床事件与肥厚程度相关。据报道,成年HCM患者的主动脉僵硬度高于对照组患者。僵硬度增加可能导致更多的左心室肥厚,从而引发更多的临床事件。我们试图(a)通过无创方法比较肌节型HCM基因型青年与对照青年之间的主动脉结构和功能,以及(b)探讨主动脉功能与左心室(LV)肥厚程度之间的关系。在一个单一转诊中心进行的前瞻性研究中,收集了28例连续的致病性HCM基因突变携带者和26例无关对照者(平均年龄16.3岁,50%为女孩)的临床、人体测量和血流动力学数据。血流动力学数据包括压平式眼压测量的中心脉压、颈股脉搏波速度(CFPWV)、反射波增强指数(AIx)。在HCM基因携带者中,从临床指示的超声心动图中提取左心室质量与容积比作为肥厚指标。使用多变量调整线性回归评估相关性。HCM组包括14例肌球蛋白结合蛋白C3携带者、13例肌球蛋白重链7携带者和1例同时携带两者的儿童。HCM组和对照组在年龄、性别、身高、体重指数、心率或血压方面无差异。HCM携带者的CFPWV显著低于对照组(4.46±0.88 vs. 4.97±0.44 m/s,p = 0.01),AIx幅度更高(27±19 vs. 18±7%,p = 0.04)。在调整年龄、性别、身高、心率、平均压力和药物使用后,这些相关性仍然存在。在HCM组中,左心室肥厚与AIx相关,但与CFPWV无关。CFPWV和AIx在基因型上没有差异。携带HCM基因突变的青年的主动脉僵硬度似乎较低,但波反射似乎较高。在这个高危队列中,波反射程度似乎与左心室肥厚相关,这表明减轻波反射可能会减轻左心室肥厚。